Health Care & Life Sciences » Biotechnology | Theravance Biopharma Inc.

Theravance Biopharma Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
226.00
11,688.00
42,126.00
48,648.00
15,386.00
60,370
Cost of Goods Sold (COGS) incl. D&A
-
4,058.00
4,657.00
4,453.50
6,030.00
3,881
Gross Income
-
7,630.00
37,469.00
44,194.50
9,356.00
56,489
SG&A Expense
153,857.00
240,169.00
219,368.00
224,661.50
269,479.00
295,240
EBIT
156,284.00
232,539.00
181,899.00
180,467.00
260,123.00
238,751
Unusual Expense
-
-
-
-
8,000.00
-
Non Operating Income/Expense
-
1,565.00
-
-
-
11,966
Interest Expense
-
-
-
1,404.00
8,547.00
10,482
Pretax Income
156,284.00
230,674.00
181,268.00
180,559.00
271,711.00
226,085
Income Tax
-
6,364.00
951.00
10,110.00
13,694.00
10,561
Consolidated Net Income
156,284.00
237,038.00
182,219.00
190,669.00
285,405.00
215,524
Net Income
156,284.00
237,038.00
182,219.00
190,669.00
285,405.00
215,524
Net Income After Extraordinaries
156,284.00
237,038.00
182,219.00
190,669.00
285,405.00
215,524
Net Income Available to Common
156,284.00
237,038.00
182,219.00
190,669.00
285,405.00
215,524
EPS (Basic)
4.90
7.46
5.34
4.26
5.45
3.99
Basic Shares Outstanding
31,900.00
31,755.00
34,150.00
44,711.00
52,352.00
53,969
EPS (Diluted)
4.90
7.46
5.34
4.26
5.45
3.99
Diluted Shares Outstanding
31,900.00
31,755.00
34,150.00
44,711.00
52,352.00
53,969
EBITDA
153,631.00
229,877.00
179,399.00
177,348.00
256,096.00
235,585
Non-Operating Interest Income
-
300.00
631.00
1,312.00
4,959.00
11,182

About Theravance Biopharma

View Profile
Address
Ugland House
George Town GT KY1
Cayman Islands
Employees -
Website http://www.theravance.com
Updated 07/08/2019
Theravance Biopharma, Inc. operates as a biopharmaceutical company, which focuses on the discovery, development and commercialization of small molecule medicines. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.